Apoptosis and cancer chemotherapy

@article{Makin2000ApoptosisAC,
  title={Apoptosis and cancer chemotherapy},
  author={G. Makin and J. Hickman},
  journal={Cell and Tissue Research},
  year={2000},
  volume={301},
  pages={143-152}
}
Abstract Apoptosis is a fundamental mechanism of cell death that can be engaged by a range of cellular insults. One of the major modes of action of chemotherapeutic drugs may be via the activation of apoptosis. Understanding how the cell death program is engaged following an insult, and hence why it fails to be engaged in certain settings, offers a novel approach to overcoming the clinical problem of drug resistance. The tumour suppressor gene p53 and its downstream effector genes p21, mdm-2… Expand
Modulating apoptosis as a target for effective therapy.
TLDR
It has been shown that gene therapy may be an encouraging approach for treatment of neurodegenerative disorders and apoptosis of tumor cells can be achieved by targeting the inhibitor of apoptosis proteins, IAPs, in addition to the classical antiproliferative approach. Expand
2 Resistance to Apoptosis in Cancer Therapy
An enormous body of work has established that conventional cancer therapies induce apoptosis in tumor cell lines and preclinical models of human disease. Parallel efforts have defined theExpand
The Intrinsic Pathway of Apoptosis
Virtually all anticancer drugs induce apoptosis in susceptible cell types. This biochemically distinct form of cell death reflects, in large part, activation of caspases, a distinct family ofExpand
Apoptosis-targeted therapies for cancer.
TLDR
It remains to be determined to what extent toxicity to normal tissues will limit application of apoptosis-based therapies for cancer treatment, and hope that improved clinical outcomes may not be far from realization is offered. Expand
Apoptosis and Molecular Targeting Therapy in Cancer
TLDR
The main regulatory molecules that govern the main basic mechanisms, extrinsic and intrinsic, of apoptosis in normal cells are provided and how carcinogenesis could be developed via defective apoptotic pathways or their convergence is discussed. Expand
Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B.
TLDR
In other cancer cells that are resistant to TNFalpha or chemo/radiotherapy, Smac-mimetic IAP-inhibitors can enhance ionizing radiation or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis, indicating the potential role of Smac -mimetics in overcoming acquired therapy-resistance. Expand
BMX Negatively Regulates BAK Function, Thereby Increasing Apoptotic Resistance to Chemotherapeutic Drugs.
TLDR
The finding that BMX directly inhibits a core component of the intrinsic apoptosis machinery opens opportunities to improve the efficacy of existing chemotherapy by potentiating BAK-driven cell death in cancer cells. Expand
Mitochondrial targeting drug lonidamine triggered apoptosis in doxorubicin-resistant HepG2 cells.
TLDR
A potential use of LND as an anti-cancer drug to bypass drug resistance and to trigger tumour destruction through apoptosis in HepG2 and R-HepG2 cells is suggested. Expand
Turning cell cycle controller genes into cancer drugs. A role for an antiproliferative cytokine (betaGBP).
TLDR
The use of betaGBP is discussed within the context of cancer surveillance and cancer therapeutics focussing on E2F1 as one mechanistic aspect relevant tobetaGBP's selective induction of programmed cell death in cancer. Expand
Apoptosis: programmed cell death at a molecular level.
TLDR
How deregulation of apoptosis may contribute to autoimmunity, cancer, and neurodegenerative disorders and strategies some viruses have evolved that interfere with the host's apoptotic pathways are described. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 99 REFERENCES
Apoptosis and chemotherapy resistance.
  • J. Hickman
  • Biology, Medicine
  • European journal of cancer
  • 1996
TLDR
The resurgence of interest over the past five years in the phenomenon of cell death was largely stimulated by the discovery of genetic determinants of cellular survival and cell death, including conservation of sequence between some of the death regulating genes required for the proper development of the nematode worm Cuenorhabditis eleguns and those of man. Expand
7 Apoptosis: Its role in drug sensitivity and resistance
TLDR
The finding that all cytotoxic chemotherapeutic drugs initiate apoptosis is important because the genes which control cell death will modulate the response of cells to cytot toxic drug-induced damage. Expand
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
TLDR
It is demonstrated that an oncogene, specifically the adenovirus E1A gene, can sensitize fibroblasts to apoptosis induced by ionizing radiation, 5-fluorouracil, etoposide, and adriamycin, and the involvement of p53 in the apoptotic response suggests a mechanism whereby tumor cells can acquire cross-resistance to anticancer agents. Expand
Apoptosis , p 53 , and Tumor Cell Sensitivity to Anticancer Agents 1
A widely held tenet of present day oncology is that tumor cells treated with anticancer agents die from apoptosis, and that cells resistant to apoptosis are resistant to cancer treatment. We suggest,Expand
Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors.
TLDR
Microenvironmental factors reduce the sensitivity of a B-cell lymphoma to etoposide in vitro by modulating the expression and functions of Bax and Bcl-x(L), which may provide a paradigm for epigenetically induced drug resistance in other tumors. Expand
Does Apoptosis Contribute to Tumor Cell Sensitivity to Anticancer Agents
TLDR
If clonogenic survival is used to assess cell killing, and real tumor cells are used, then apoptosis, and the genes controlling it, play little or no role in the sensitivity of tumor cells of nonhematological origin to anticancer drugs and radiation. Expand
A model for p53-induced apoptosis
TLDR
Examination of transcripts induced by p53 expression before the onset of apoptosis stimulated additional biochemical and pharmacological experiments suggesting that p53 results in apoptosis through a three-step process: the transcriptional induction of redox-related genes; the formation of reactive oxygen species; and the oxidative degradation of mitochondrial components, culminating in cell death. Expand
Drug-target interactions: only the first step in the commitment to a programmed cell death?
TLDR
It is argued that it is possible that the outcome of chemotherapy may be determined by the response of the cell to the formation of the drug-target complex, and/or its sequellae, rather than to the biochemical changes brought about by the drug alone. Expand
Bax suppresses tumorigenesis and stimulates apoptosis in vivo
TLDR
It is shown that p53-dependent expression of bax is induced in slow-growing apoptotic tumours, and this is the first demonstration that Bax acts as a tumour suppressor, and the findings indicate that bax could be a component of the p 53-mediated apoptotic response in this system. Expand
Apoptosis in cancer therapy: Crossing the threshold
TLDR
Emerging evidence suggests that, owing to varying apoptosis thresh- olds, treatments may induce apoptosis in tumor cells, but merely a cell cycle pause in their normal cell counterparts, and a major mode of resistance to antitumor treatments may be insensitivity to apoptosis induction. Expand
...
1
2
3
4
5
...